Multiple Daily Fractionation (MDF) in Association with Misonidazole (MIS): A Two-Year Experience with Head and Neck Cancer

  • G. Arcangeli
  • F. Mauro
  • C. Nervi
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 43)


In our Institution MDF schemes have been introduced several years ago (1,2). One of the main reasons for developing and testing this kind of scheme is the possibility of compressing the radiation dose in time, thus allowing a better exploitation of hypoxic cell radiosensitizers administration within the well-known toxicity limits. Further, other radiobiological criteria may justify the use of non-conventional fractionation per se (and of local hyperthermia) on radioresistant tumours with a presumably high fraction of hypoxic cells.


Multimodality Treatment Hypoxic Cell Conventional Fractionation Historical Series Neck Node Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G. Arcangeli, F. Mauro, D. Morelli and C. Nervi, Multiple daily fractionation in radiotherapy: biological rationale and preliminary clinical experiences, Europ. J. Cancer 15: 1077 (1979).CrossRefGoogle Scholar
  2. 2.
    G. Arcangeli, E. Barni, A. Cividalli, F. Mauro, D. Morelli, C. Nervi, M. Spano and A. Tabocchini, Effectiveness of microwave hyperthermia combined with ionizing radiation: Clinical results on neck node metastases, Int. J. Radiat. Oncol. Biol. Phys. 6:143 (1980).PubMedCrossRefGoogle Scholar
  3. 3.
    R. C. Urtasun, J. Sturmwind, H. Rabin, T.R. Band and J.D. Chapman, ‘High dose’ metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials, Br. J. Radiol. 47:297 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    G. Arcangeli, A. Barocas, F. Mauro, C. Nervi, M. Spano and A. Tabocchini, Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: Experimantal and clinical results, Cancer 45:2707 (1980).PubMedCrossRefGoogle Scholar
  5. 5.
    S. Dische, M.I. Saunders, M.E. Lee, G.E. Adams and I.R. Flockhart, Clinical testing of the radiosensitizer Ro 07–0582: Experience with multiple doses, Br. J. Cancer 35:567 (1977).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • G. Arcangeli
    • 1
  • F. Mauro
    • 2
  • C. Nervi
    • 1
  1. 1.Istituto Medico e di Ricerca ScientificaRomeItaly
  2. 2.Comitato Nazionale per l’Energia NucleareRomeItaly

Personalised recommendations